Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Shares Issued (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Shares Issued for 3 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 168.54% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $12.4 million for FY2025, N/A changed from the prior year.
  • Shares Issued hit $4.3 million in Q4 2025 for Immunocore Holdings, up from $1.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $17.7 million in Q2 2023 to a low of -$6.2 million in Q4 2024.
  • Historically, Shares Issued has averaged $4.2 million across 3 years, with a median of $3.7 million in 2025.
  • Biggest five-year swings in Shares Issued: plummeted 199.94% in 2024 and later skyrocketed 1131.54% in 2025.
  • Year by year, Shares Issued stood at $6.3 million in 2023, then tumbled by 199.94% to -$6.2 million in 2024, then surged by 168.54% to $4.3 million in 2025.
  • Business Quant data shows Shares Issued for IMCR at $4.3 million in Q4 2025, $1.9 million in Q3 2025, and $3.7 million in Q2 2025.